Wordt geladen...
Prophylactic or Early Use of Eculizumab and Graft Survival in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome in the United States: Research Letter
INTRODUCTION: Among kidney transplant recipients (KTRs) with end-stage kidney disease (ESKD) due to atypical hemolytic uremic syndrome (aHUS), recurrence is associated with poor allograft outcomes. We compared graft and patient survival of aHUS KTRs with and without prophylactic/early use of eculizu...
Bewaard in:
| Gepubliceerd in: | Can J Kidney Health Dis |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020226/ https://ncbi.nlm.nih.gov/pubmed/33868691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20543581211003763 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|